AN2 Therapeutics
ANTX
#8920
Rank
NZ$0.35 B
Marketcap
NZ$9.29
Share price
-2.68%
Change (1 day)
378.38%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2026 (TTM): -NZ$67.43 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$69.67 Million, an increase over its 2024 earnings that were of -NZ$99.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$67.43 Million-3.21%
2025 -NZ$69.67 Million-30.14%
2024 -NZ$99.73 Million-21.66%
2023 -NZ$0.13 Billion64.77%
2022 -NZ$77.26 Million95.89%
2021 -NZ$39.44 Million